The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...
Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
On this episode of Not So Different, we explore the Federal Trade Commission’s (FTC) second interim report on pharmacy benefit managers (PBMs) with Joe Wisniewski from Turquoise Health, discussing key ...
Number 4: The FDA and European Medicines Agency (EMA) granted approval, with interchangeability in the US, to Samsung Bioepis ...
Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback